Free EDC Software for Non-Profit COVID-19 Related Studies
Italy-based EDC provider, Nubilaria srl, is offering its ACTide EDC free-of-charge for non-profit COVID-19 related studies due to be performed in Europe. ACTide EDC software is a validated, FDA 21 Part 11 compliant platform featuring native drag and drop eCRFs Designer and modules including RTSM, ePRO, medical coding (MedDRA and WHODurgs) and Safety Dataset.
Nubilaria pledges its maximum commitment possible toward a fast study deployment for all received requests.
The offer applies only to public bodies and any other entity involved in non-profit research.
For further information and to request a demo of the offered service, please visit:
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- How the NIMBLE Study Supported Adherence With Quarterly Dosing of Cemdisiran
September 18th 2025
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025